Biomedical Research, Science, & Technology

In 2011, the U.S. federal government launched the Strong Cities, Strong Communities Initiative, a new model of federal-local collaboration designed to (i) improve how the federal government invests in cities, (ii) offer technical assistance to support local priorities, and (iii) help to coordinate funds at the local, state, and federal level.

In 2011, the U.S. federal government launched the Strong Cities, Strong Communities Initiative, a new model of federal-local collaboration designed to (i) improve how the federal government invests in cities, (ii) offer technical assistance to support local priorities, and (iii) help to coordinate funds at the local, state, and federal level.

Pharmaceutical companies conduct clinical trials for many reasons. The most obvious goal of clinical trials is to demonstrate safety and efficacy to gain Food and Drug Administration (FDA) approval. FDA provides guidance to developers about what constitutes acceptable clinical trials and appropriate outcomes.

This PDF was submitted as an attachment to a Public Comment sent to the Advisory Council on Alzheimer's Research, Care, and Services and/or the National Alzheimer's Project Act website.

Antibacterial resistance is a growing global problem. At least 2 million people in the U.S. acquire serious infections with bacteria that are resistant to one or more of antibacterial drugs designed to treat it.

The 2015 President’s Budget proposes major new investments to build the health care workforce and improve the delivery of health care services, particularly primary care services, across the nation.

Michelle Dougherty and Margaret Williams AHIMA Foundation Michael Millenson Health Quality Advisors LLC Jennie Harvell U.S. Department of Health and Human Services June 2013